Calls Purchased on BioMimetic Therapeutics

Shares of BioMimetic Therapeutics BMTI are lower on the session by 0.21%, currently trading at $4.69. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are buying calls on the name today. A short while ago the July 2011 $5.00 call traded 1,000 times on open interest of 277 contracts. Overall call volume is now running at 3.64x the daily average with 81% of all calls traded being purchases on the offer. BioMimetic Therapeutics, Inc. is a biotechnology company, which develops and commercializes products to help stimulate the body's natural tissue regenerative process.